Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference 2024-01-11 11:53
Robooter Showcases Innovative Power Wheelchair X40 at CES 2024 2024-01-11 01:00
New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA 2024-01-10 16:50
LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024 2024-01-10 08:55
Medicilon appoints Dr. Zhang Haizhou as President of Preclinical R&D Unit 2024-01-09 21:30
Toratani Co., Ltd. Unveils Groundbreaking "Virtuous Circulation Pillow and Mattress" with Patented Technology for Enhanced Deep Breathing Experience 2024-01-09 21:00
Baopu Development Joins IWBI's WELL for Residential Program 2024-01-09 16:32
Enhancing Leadership in Gynecology, Asieris Pharmaceuticals Appoints Sophia Cao to Lead the Newly-Established Women's Health Business Unit, Accelerating Strategic Expansion 2024-01-09 12:25
Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib (ABSK021) 2024-01-09 08:30
WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site 2024-01-08 22:00
Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap 2024-01-08 21:38
Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC) 2024-01-08 19:35
So-Young Announces Update on Repurchase and Cancellation of Shares 2024-01-08 19:00
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts 2024-01-08 17:52
Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum's Disease 2024-01-08 13:25
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis 2024-01-08 07:00
Nuvilab Innovates Inpatient Nutrition with Food AI at Alexandra Hospital Singapore 2024-01-05 22:46
Supplemental New Drug Application for Akeso's Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer 2024-01-05 21:00
Grant of Restricted Share Units to Mr. Xing Jin 2024-01-05 19:00
SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease 2024-01-05 16:00
1 53 54 55 56 57 812